NYSE - Delayed Quote • USD
Laboratory Corporation of America Holdings (LH)
At close: April 26 at 4:00 PM EDT
After hours: April 26 at 6:55 PM EDT
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 14 | 14 | 18 | 18 |
| Avg. Estimate | 3.82 | 3.78 | 14.8 | 15.98 |
| Low Estimate | 3.66 | 3.69 | 14.5 | 15.46 |
| High Estimate | 3.94 | 3.9 | 15 | 16.82 |
| Year Ago EPS | 3.42 | 3.38 | 13.56 | 14.8 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 13 | 13 | 17 | 17 |
| Avg. Estimate | 3.2B | 3.23B | 12.79B | 13.38B |
| Low Estimate | 3.18B | 3.2B | 12.66B | 12.93B |
| High Estimate | 3.25B | 3.26B | 12.89B | 13.88B |
| Year Ago Sales | 3.03B | -- | 12.16B | 12.79B |
| Sales Growth (year/est) | 5.50% | -- | 5.20% | 4.60% |
Earnings History
| CURRENCY IN USD | 6/30/2023 | 9/30/2023 | 12/31/2023 | 3/31/2024 |
|---|---|---|---|---|
| EPS Est. | 3.53 | 3.33 | 3.26 | 3.48 |
| EPS Actual | 3.42 | 3.38 | 3.3 | 3.68 |
| Difference | -0.11 | 0.05 | 0.04 | 0.2 |
| Surprise % | -3.10% | 1.50% | 1.20% | 5.70% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 3.82 | 3.78 | 14.8 | 15.98 |
| 7 Days Ago | 3.84 | 3.81 | 14.82 | 16.04 |
| 30 Days Ago | 3.81 | 3.79 | 14.82 | 16.06 |
| 60 Days Ago | 3.81 | 3.8 | 14.82 | 16.08 |
| 90 Days Ago | 3.68 | 3.68 | 14.61 | 15.98 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | 1 | 1 | 3 | 2 |
| Up Last 30 Days | 4 | 5 | 4 | 3 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | 4 | 4 | 3 | 4 |
Growth Estimates
| CURRENCY IN USD | LH | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | 11.70% | -- | -- | 6.50% |
| Next Qtr. | 11.80% | -- | -- | 12.00% |
| Current Year | 9.10% | -- | -- | 5.30% |
| Next Year | 8.00% | -- | -- | 13.10% |
| Next 5 Years (per annum) | 7.78% | -- | -- | 11.09% |
| Past 5 Years (per annum) | 8.18% | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
| Maintains | Truist Securities: Buy to Buy | 4/26/2024 |
| Maintains | Barclays: Equal-Weight to Equal-Weight | 4/26/2024 |
| Maintains | Baird: Outperform to Outperform | 4/26/2024 |
| Upgrade | Argus Research: Hold to Buy | 3/25/2024 |
| Initiated | Leerink Partners: Outperform | 2/26/2024 |
| Initiated | Evercore ISI Group: In-Line | 2/9/2024 |
Related Tickers
DGX Quest Diagnostics Incorporated
134.26
-0.86%
NVTAQ Invitae Corporation
0.0005
-94.44%
TMO Thermo Fisher Scientific Inc.
573.60
+0.33%
DHR Danaher Corporation
246.58
+0.32%
CRL Charles River Laboratories International, Inc.
229.03
+0.54%
ICLR ICON Public Limited Company
308.31
+2.74%
IQV IQVIA Holdings Inc.
234.88
+0.38%
MEDP Medpace Holdings, Inc.
395.93
+1.58%
WAT Waters Corporation
311.30
+0.96%
ILMN Illumina, Inc.
122.28
+1.02%